SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
mehr
Ergebnis der Suchanfrage nach Dü
Inhalte
- Kategorie:
- Sprache:
-
Medien:
Alle
- Zeitraum:
- Zeitraum:Gesamt
2670 Treffer
Bosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
mehrGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
mehrBIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...
mehrNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
mehr- 6
Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025
Ein Dokumentmehr
Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®
London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...
mehrHellmann: Martin Habisreitinger appointed COO Airfreight
mehrMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
mehr- 3
Hellmann helps supports voluntary engagement
mehr Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehrTechnische Universität München
New method for designing artificial proteins
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Designing large new proteins with AI New method for designing artificial proteins - Efficient design of new proteins with desired properties - Size of newly designed proteins is approaching that of antibodies - Predicted protein structures successfully validated in experiments Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or ...
mehr
- 2
Hellmann advances innovation with AI-RobotX MEA and Geekplus to enhance eCommerce fulfillment operations
mehr - 6
Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award
Ein Dokumentmehr LAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024
Ein Dokumentmehr- 5
LAMILUX renovation solutions: Customised, cost-effective and energy-efficient!
Ein Dokumentmehr - 2
Hellmann launches next growth phase with new global leadership structure
mehr - 5
Advanced Recycling Conference 2024 – Driving Innovation in Sustainable Materials Management
Ein Dokumentmehr
- 2
Hellmann: Enrico Farneti appointed Managing Director of Hellmann Italy
mehr Rohde & Schwarz technology group closes fiscal year successfully in dynamic market environment
Munich (ots) - Rohde & Schwarz has closed the 2023/2024 fiscal year successfully in a market environment that remains highly dynamic. The company again achieved year-on-year increases in both revenue and incoming orders. With its three divisions Test & Measurement, Technology Systems and Networks & Cybersecurity, the group addressed the current challenges. The ...
mehrNew study highlights misalignment of gas infrastructure planning and decarbonisation goals
Joint press release by Oeko-Institut and RAP Berlin, 30. October 2024 New study highlights misalignment of gas infrastructure planning and decarbonisation goals Reforming the regulation of gas distribution systems will be crucial to aligning future energy demand with decarbonisation goals and protecting consumers, concludes a new study by Oeko Institut and the ...
mehrLAUDA DR. R. WOBSER GMBH & CO. KG
Dr. Marc Stricker with LAUDA for ten years
mehrFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
mehrFirst fashion label for urns and gravestones launches in the United Kingdom
mehr
Extreme Rainfall Poses Health Risks
Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...
mehrNew market entry: Nexaro expands to British market with partner Killis
mehrGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
mehr- 2
PtX Development and KGAL sign contract for large-scale hydrogen project in Germany
Ein Dokumentmehr Awareness of life and permanence: RWK & Kuhlmann presents its first collection for Villeroy & Boch
mehr- 11
Disruption on Two Wheels - eROCKIT Roadshow Sparks Pure Excitement on the Island of Sylt
mehr
Vorherige12345678910Nächste